OnKure Therapeutics (OKUR) EPS (Basic) (2020 - 2026)
OnKure Therapeutics' (OKUR) quarterly EPS (Basic) came in at -$0.34 in Q2 2026, up 71.96% on a YoY basis from -$0.2 in Q2 2025, and up 70.32% quarter-over-quarter from -$1.14 in Q1 2026.
Powered by 
Analysis
OnKure Therapeutics (OKUR) EPS (Basic) (2020 - 2026) Analysis & Trends
OnKure Therapeutics (OKUR) has reported EPS (Basic) for 7 consecutive years, with -$0.34 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, EPS (Basic) rose 71.96% year-over-year to -$0.34; the trailing twelve-month figure through Jun 2026 stood at -$1.25 (up 73.16% YoY), and the FY2025 full-year result was -$4.4, up 71.18% from the prior year.
- EPS (Basic) improved to -$0.34 in Q2 2026 per OKUR's latest filing, from -$1.14 in the prior quarter.
- Across five years, EPS (Basic) topped out at $6.88 in Q4 2023 and bottomed at -$6.96 in Q2 2023.
- Historically, EPS (Basic) has averaged -$3.16 across 5 years, with a median of -$3.9 in 2024.
- The sharpest annual moves came in 2023 and 2024: EPS (Basic) surged 215.78% in 2023, then tumbled 179.06% in 2024.
- Over 5 years, EPS (Basic) stood at -$5.94 in 2022, then soared by 215.78% to $6.88 in 2023, then sank by 179.06% to -$5.44 in 2024, then surged by 80.79% to -$1.05 in 2025, then surged by 67.59% to -$0.34 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.34, -$1.14, and -$1.05 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 4.40 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -8.44 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 4.34 |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 12.62 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 7.70 |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -1.96 |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 1.23 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 0.66 |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -0.40 |
| 10 | OnKure Therapeutics | 162.57 Mn | -13.81 Mn | - | -0.34 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.34 |
| Mar 31, 2026 | -1.14 |
| Dec 31, 2025 | -1.05 |
| Sep 30, 2025 | -1.15 |
| Jun 30, 2025 | -1.21 |
| Mar 31, 2025 | -1.19 |
| Dec 31, 2024 | -5.44 |
| Sep 30, 2024 | -3.51 |
| Jun 30, 2024 | -4.30 |
| Mar 31, 2024 | -2.85 |
| Dec 31, 2023 | 6.88 |
| Sep 30, 2023 | -6.18 |
| Jun 30, 2023 | -6.96 |
| Mar 31, 2023 | -6.44 |
| Dec 31, 2022 | -5.94 |
| Sep 30, 2022 | -5.65 |
| Jun 30, 2022 | -5.08 |
| Mar 31, 2022 | -5.32 |
| Dec 31, 2021 | -5.86 |
| Sep 30, 2021 | -5.23 |